. Author manuscript; available in PMC: 2018 Jan 1.

Published in final edited form as: Arthritis Care Res (Hoboken). 2016 Nov 21;69(1):5–11. doi: 10.1002/acr.22992

Table 2.

Baseline Demographics of SLE Cases with and without Depression

	SLE Cases Not Depressed N=106	SLE Cases Depressed N=43	p value

Traditional CVD Risk Factors
Age (years), mean (SD)	48.28 (10.86)	49.36 (7.96)	0.504
African American, n (%)	26 (24.53%)	16 (37.21%)	0.189
Body Mass Index (kg/m²), mean (SD)	27.38 (7.47)	30.98 (9.09)	0.014
Current Smoker, n (%)	6 (5.71%)	4 (9.30%)	0.477
Systolic Blood Pressure (mmHg), mean (SD)	113.08 (14.60)	116.30 (16.13)	0.239
Diabetes, n (%)	6 (5.66%)	4 (9.30%)	0.475
Total cholesterol: HDL ratio, mean (SD)	3.60 (145)	3.90 (1.33)	0.250
Serum creatinine, mean (SD)	0.98 (1.36)	0.83 (0.22)	0.296
Statin use, n (%)	22 (20.75%)	7 (16.28%)	0.532
Aspirin use, n (%)	22 (20.75%)	15 (34.88%)	0.071
Prednisone use, n (%)	33 (31.1%)	23 (53.5%)	0.011
Prednisone dose, mean (SD)^*	13.4 (9.83)	10.1 (6.34)	0.135
SLE-Related Factors
SLICC/ACR-DI, mean (SD)	2.62 (2.83)	2.95 (1.81)	0.640
SLEDAI-2K, mean (SD)	2.21 (2.41)	2.60 (1.81)	0.293
Depression-related factors
CES-D , mean (SD)	5.75 (4.59)	25.70 (8.25)	<.0001

Of 23 depressed and 33 not depressed patients taking prednisone at baseline visit